Sales & Marketing News | pharmaphorum

News

FDA clears J&J's 2-in-1 tablet for prostate cancer

Johnson & Johnson has been given FDA approval for Akeega, a combination tablet for first-line treatment of adults with BRCA-positive metastatic castration-resistant pr

News

US pharmacists say drug shortages are affecting cancer care

More than half of hospital pharmacists in the US have said they are experiencing "major challenges" getting access to cancer therapies, according to a new poll.

News

Novo Nordisk buys Inversago for $1bn as Wegovy sales soar

Sales of its obesity therapies may be accelerating, but Novo Nordisk is showing no signs of pushing the brake pedal on investments in the category.

News

eureKING buys SCTbio to extend biomanufacturing push

Special purpose acquisition company (SPAC) eureKING has agreed a deal to buy SCTbio as part of a plan to build a contract manufacturing company specialising in biologic th

News

Mirati CEO David Meek steps down after Krazati setback

Mirati Therapeutics chief executive David Meek has agreed to step down by mutual agreement with the company's board, to be replaced on a temporary basis by founder and for

News

Novavax swings to profit as it preps new COVID jab launch

Just a few months after suggesting it may not survive to the end of 2023, Novavax has posted improved finances and a second-quarter profit, as it readies the launch of an

FDA clears J&J's 2-in-1 tablet for prostate cancer

US pharmacists say drug shortages are affecting cancer care

Novo Nordisk buys Inversago for $1bn as Wegovy sales soar

eureKING buys SCTbio to extend biomanufacturing push

Mirati CEO David Meek steps down after Krazati setback

Novavax swings to profit as it preps new COVID jab launch

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks